Whiteoak Capital Pharma and Healthcare Fund
WhiteOak Capital Mutual Fund · FM: Piyush Baranwal, Ramesh Mantri, Trupti Agrawal, Dheeresh Pathak, Ashish Agrawal · INF03VN01886 · Direct
NAV ₹17.79 AUM ₹741 Cr as of 22 Sep 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:28 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +1.2% | +9.0% | +27.0% | +23.4% | — | — | 9/234 | 1.08% |
Equity allocation
92.09%
Non-equity allocation (combined)
7.91%
All Equity Holdings (49) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 64.2 | 8.66% | — |
| 2 | J.B. Chemicals & Pharmaceuticals Ltd | 51.5 | 6.94% | — |
| 3 | Laurus Labs Ltd | 34.2 | 4.61% | — |
| 4 | Apollo Hospitals Enterprise Ltd | 34.1 | 4.59% | — |
| 5 | Max Healthcare Institute Ltd Ordinary Shares | 31.9 | 4.30% | — |
| 6 | Fortis Healthcare Ltd | 26.8 | 3.62% | — |
| 7 | Krishna Institute of Medical Sciences Ltd | 24.5 | 3.30% | — |
| 8 | Cipla Ltd | 24.1 | 3.25% | — |
| 9 | Sai Life Sciences Ltd | 23.8 | 3.22% | — |
| 10 | Aurobindo Pharma Ltd | 19.9 | 2.69% | — |
| 11 | Corona Remedies Ltd | 18.8 | 2.54% | — |
| 12 | Neuland Laboratories Ltd | 18.3 | 2.47% | — |
| 13 | Acutaas Chemicals Ltd | 17.6 | 2.38% | — |
| 14 | Zydus Lifesciences Ltd | 16.4 | 2.21% | — |
| 15 | Thyrocare Technologies Ltd | 15.6 | 2.10% | — |
| 16 | Gland Pharma Ltd | 14.7 | 1.98% | — |
| 17 | Dr. Lal PathLabs Ltd | 14.3 | 1.94% | — |
| 18 | Granules India Ltd | 13.5 | 1.82% | — |
| 19 | Narayana Hrudayalaya Ltd | 13.0 | 1.75% | — |
| 20 | Divi's Laboratories Ltd | 12.4 | 1.68% | — |
| 21 | Ajanta Pharma Ltd | 12.2 | 1.65% | — |
| 22 | Vijaya Diagnostic Centre Ltd | 11.2 | 1.51% | — |
| 23 | Rainbow Childrens Medicare Ltd | 10.8 | 1.46% | — |
| 24 | Aether Industries Ltd | 10.0 | 1.35% | — |
| 25 | Shaily Engineering Plastics Ltd | 10.0 | 1.35% | — |
| 26 | Procter & Gamble Health Ltd | 9.7 | 1.31% | — |
| 27 | Navin Fluorine International Ltd | 9.1 | 1.23% | — |
| 28 | OneSource Specialty Pharma Ltd | 9.1 | 1.23% | — |
| 29 | Glenmark Pharmaceuticals Ltd | 8.7 | 1.17% | — |
| 30 | Anthem Biosciences Ltd | 8.4 | 1.14% | — |
| 31 | Innova Captab Ltd | 8.3 | 1.12% | — |
| 32 | Kovai Medical Center & Hospital Ltd | 8.0 | 1.08% | — |
| 33 | Poly Medicure Ltd | 7.5 | 1.01% | — |
| 34 | Pfizer Ltd | 7.1 | 0.95% | — |
| 35 | Ipca Laboratories Ltd | 6.8 | 0.92% | — |
| 36 | Aarti Pharmalabs Ltd | 6.4 | 0.86% | — |
| 37 | Strides Pharma Science Ltd | 6.3 | 0.85% | — |
| 38 | Supriya Lifescience Ltd | 5.8 | 0.78% | — |
| 39 | Senores Pharmaceuticals Ltd | 5.6 | 0.75% | — |
| 40 | Jupiter Life Line Hospitals Ltd | 5.4 | 0.73% | — |
| 41 | Vimta Labs Ltd | 5.2 | 0.70% | — |
| 42 | Zota Health Care Ltd | 4.1 | 0.55% | — |
| 43 | Nephrocare Health Services Ltd | 3.9 | 0.52% | — |
| 44 | Sudeep Pharma Ltd | 3.8 | 0.51% | — |
| 45 | Aster DM Quality Care Ltd Ordinary Shares | 2.7 | 0.37% | — |
| 46 | Orchid Pharma Ltd | 2.2 | 0.29% | — |
| 47 | Cohance Lifesciences Ltd | 1.9 | 0.26% | — |
| 48 | Laxmi Dental Ltd | 1.6 | 0.21% | — |
| 49 | Tatva Chintan Pharma Chem Ltd | 1.3 | 0.18% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.